News | March 28, 2011

SNM Enhances Education Program for 2011 Annual Meeting

March 28, 2011 – The Society of Nuclear Medicine’s (SNM) 2011 Annual Meeting, June 4-8 in San Antonio, offers a variety of new education options to nuclear medicine and molecular imaging professionals. With new topics, formats and technologies, the meeting provides a comprehensive review of the latest research and issues in the field.

"In planning the education offerings for the annual meeting, we look to provide attendees with programming that will increase their professional effectiveness, allowing them to examine and evaluate future directions in nuclear medicine, molecular imaging and therapy from both research and clinical perspectives,” said Peter Herscovitch, M.D., chair of SNM’s scientific program committee. “The program combines the latest advances in basic sciences with state of the art reviews of oncology, cardiology and neurology applications."

This year, new topics at SNM include healthcare reform, the future of nuclear medicine from the physicians’ perspective, an update on radioimmunotherapy and use of generator-produced Ga-68. Three hybrid sessions — featuring a mix of basic science, translational and clinical approaches — will be presented on breast cancer, neuroimaging and infection.

In addition, SNM will host several courses on dose reduction and radiation safety. Continuing education courses developed by SNM include those on pediatric dose reduction, reducing patient radiation exposure while improving diagnostic testing, standards of excellence and more.

For the first time, SNM will host a Nuclear Cardiology Technology workshop. There will also be six integrated scientific sessions — sessions that combine abstract presentations with a featured guest speaker. Self-assessment modules for the maintenance of certification program will be back as well.

During the plenary sessions, questions will be taken via text message and Twitter. Also new, SNM will capture 70 sessions and post them online as a virtual meeting available afterwards. The virtual meeting, with pre-meeting, on-site and post-meeting pricing, will include 35 continuing education sessions, 20 technologist sessions and 15 scientific sessions.

"SNM strives improve its content each year, adapting to the changing needs of nuclear medicine and molecular imaging professionals," said Herscovitch. "We have a strong program this year and look forward to a successful meeting."

The SNM Annual Meeting is the foremost educational and networking event in molecular imaging and nuclear medicine. The meeting attracts more than 5,000 scientists, physicians, pharmacists and technologists in the molecular imaging and nuclear medicine fields.

Attendees can choose full meeting registration or a weekend-only registration. Registration is required to receive credit for attending the sessions.

For more information: www.snm.org/am2011

Related Content

PET Tracer Gauges Effectiveness of Promising Alzheimer's Treatment

Longitudinal PET imaging with 18F-AV45. PET imaging shows the average 18F-AV45 uptake per animal group at 8 and 13 months of age. A significant interaction of genotype treatment was observed in the cortex (p = 0.0248), hippocampus (p = 0.0071) and thalamus (p = 0.0084), indicating reduced [18F]-AV45 uptake in BACE1 inhibited transgenic mice. Credit: MICA, University of Antwerp, Belgium.

News | Radiopharmaceuticals and Tracers | December 28, 2017
In the December featured basic science article in The Journal of Nuclear Medicine, Belgian researchers report on the...
Vital Unveils Newest Vitrea Advanced Visualization Release at RSNA 2017
Technology | Advanced Visualization | December 04, 2017
Vital Images unveiled the newest version of Vitrea Advanced Visualization software, the cornerstone of its imaging...
Michael J. Fox Foundation and Tau Consortium Developing PET Tracers for Neurodegenerative Disease
News | Radiopharmaceuticals and Tracers | October 27, 2017
The Michael J. Fox Foundation for Parkinson's Research (MJFF) and the Tau Consortium announced a funding partnership to...
Netherlands Cancer Institute Exploring Molecular Imaging Technology for Prostate Cancer Surgery
News | Molecular Imaging | October 26, 2017
The Netherlands Cancer Institute (NKI) announced it has received funding from the Dutch Cancer Society (KWF...
SNMMI Publishes New FDG PET/CT Appropriate Use Criteria
News | PET-CT | October 25, 2017
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has published appropriate use criteria (AUC) for FDG PET/...
Biodex Unveils Atomlab 500 Dose Calibrator and Wipe Test Counter
Technology | Nuclear Imaging | October 19, 2017
Biodex Medical Systems announced the full release of the Atomlab Dose Calibrator and Wipe Test Counter to the market...
ASNC and ASE Team Up to Expand ImageGuide Registry
News | Cardiovascular Ultrasound | October 12, 2017
The American Society of Nuclear Cardiology (ASNC) and the American Society of Echocardiography (ASE) jointly announced...
MR Solutions Showcases Multimodality MRI Solutions on Two Continents
News | Magnetic Resonance Imaging (MRI) | October 11, 2017
October 11, 2017 — MR Solutions took their cryogen-free preclinical multimodality...
Majority of Recurrent Prostate Cancer Patients' Treatment Plan Changed Following Fluciclovine 18F PET/CT
News | Prostate Cancer | October 04, 2017
Blue Earth Diagnostics recently announced the results of a pre-planned interim analysis from an investigational...
News | Business | September 19, 2017
September 19, 2017 — Invicro LLC, a provider of imaging services and software for research and drug development, anno
Overlay Init